IGM Biosciences will stop working in cancer and shrink its T cell engager pipeline to focus on autoimmune diseases, the ...

A New York federal judge dismissed allegations on Monday that Bristol Myers Squibb purposely delayed Breyanzi’s approval to ...

A court ruling Friday will open the door to the FDA more tightly regulating stem cell clinics and a commonly-used stem cell ...

Johnson & Johnson has called off plans to implement a new rebate model for 340B drug price discounts following threats from ...

Ge­nom­ic med­i­cines start­up En­so­ma is shut­ter­ing its Copen­hagen site and al­so elim­i­nat­ing “a very small num­ber” ...

Kezar Life Sciences is suspending enrollment and dosing in a lupus trial after four patients died in the mid-stage study of ...

Pfizer will continue shrinking its ownership in the British consumer health company Haleon, according to an announcement ...

California Gov. Gavin Newsom vetoed bipartisan legislation on Saturday that would have reformed pharmacy benefit managers in ...

As the potential end of Robert Califf's time as FDA commissioner nears, he and a key deputy are continuing to push forward ...

Poseida Therapeutics said that 21 of 23 patients (91%) responded to the allogeneic CAR-T therapy it’s developing with Roche ...

As other young radiopharmaceutical companies get acquired by drugmakers, Boston-based Aktis Oncology wants to become one of ...

DCVC Bio confirmed it has put together a $400 million third fund, four years after raising $350 million in its sophomore ...